Precursor Immunotherapy to Prevent Squamous Cell Carcinoma
Researchers evaluated whether treatment with calcipotriol plus 5-fluorouracil aided in reducing the risk of squamous cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - April 5, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news
Topical Immunotherapy Reduces Squamous Cell Carcinoma Risk Topical Immunotherapy Reduces Squamous Cell Carcinoma Risk
A common chemotherapy combined with a synthetic vitamin D analog eliminated actinic keratosis and decreased skin cancer risk for 3 years.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 1, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Topical Immunotx for Actinic Keratosis May Prevent Cancer
MONDAY, March 25, 2019 -- A short course of calcipotriol plus 5-fluorouracil (5-FU) treatment for actinic keratosis (AK) is associated with induction of robust T cell immunity and reduced development of squamous cell carcinoma (SCC) within three... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 25, 2019 Category: Pharmaceuticals Source Type: news
Common Drug Combo Found to Cut Skin Cancer Odds
A two-ointment combo used to clear crusty skin growths known as actinic keratosis also has been found to greatly reduce the odds for squamous cell carcinomas (SCCs), the second most common form of skin cancer. (Source: WebMD Health)
Source: WebMD Health - March 22, 2019 Category: Consumer Health News Source Type: news
Immunotherapy of precancerous skin lesions may prevent squamous cell carcinoma
(Massachusetts General Hospital) A treatment previously shown to clear the precancerous skin lesions called actinic keratosis now appears to reduce the chance that the treated skin will develop squamous cell carcinomas, the second most common form of skin cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 21, 2019 Category: Cancer & Oncology Source Type: news
Topical immunotherapy keeps skin cancer risk at bay
(Washington University School of Medicine) A combination of two topical creams already shown to clear precancerous skin lesions from sun-damaged skin also lowers the risk that patients will later develop squamous cell carcinoma of the skin. The study, from Washington University School of Medicine in St. Louis, Massachusetts General Hospital, and Harvard Medical School, appears March 21 in JCI Insight. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2019 Category: International Medicine & Public Health Source Type: news
Survival Low in Some After Recurrence of Cutaneous Squamous-Cell Carcinoma Survival Low in Some After Recurrence of Cutaneous Squamous-Cell Carcinoma
Patients with cutaneous squamous-cell cancer of the head and neck who have disease recurrence after definitive treatment with surgery and postoperative radiotherapy have poor survival, according to a retrospective study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - March 14, 2019 Category: Radiology Tags: Hematology-Oncology News Source Type: news
Chest CT May Be Better Than PET/CT for HNSCC Distant Metastasis Evaluation
MONDAY, March 11, 2019 -- As distant metastasis (DM) in head and neck squamous cell carcinoma (HNSCC) is a rare event, computed tomography of the chest may be more cost-effective for evaluation, according to a study recently published in Oral... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2019 Category: Pharmaceuticals Source Type: news
Study Compares Impact of Two Therapies on Survival in Squamous Cell Carcinoma
Survival rates in patients with cSCC receiving high-dose chemoradiotherapy vs conventional radical surgery were compared. (Source: CancerNetwork)
Source: CancerNetwork - March 11, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news
Medical News Today: How aspirin may benefit some people with head and neck cancer
Regular use of aspirin or other NSAIDs increased survival in people with head and neck squamous cell carcinoma and alteration in the PIK3CA gene. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 25, 2019 Category: Consumer Health News Tags: Head and Neck Cancer Source Type: news
Amateur motorcyclist discovered he had mouth cancer after his wisdom tooth was removed
Andy Gale, 50, of Bridgwater, Somerset was told he had stage-four squamous cell carcinoma in January 2014 after the wound left behind by a removed wisdom tooth failed to heal. (Source: the Mail online | Health)
Source: the Mail online | Health - January 17, 2019 Category: Consumer Health News Source Type: news
Advanced squamous cell carcinoma of the head and neck: Pembrolizumab prolongs survival
(Institute for Quality and Efficiency in Health Care) quamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumours of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable. The goal is then to prolong the remaining lifetime while maintaining the best possible quality of life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2019 Category: International Medicine & Public Health Source Type: news
Unraveling the genetic causes of skin cancer
(American University) American University Associate Professor of Biology Katie DeCicco-Skinner and her colleagues are helping to identify the genetic factors that lead to squamous cell carcinoma. In a new paper, they show how the interaction between a cell signaling pathway called MET and a gene, Tpl2, contributes to skin cancer progression. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 13, 2019 Category: Cancer & Oncology Source Type: news
Persistent Opioid Use High in Head, Neck Cancer Patients
FRIDAY, Jan. 11, 2019 -- Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer, according to a study recently published in Otolaryngology-Head and Neck Surgery.
Jessica... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2019 Category: Pharmaceuticals Source Type: news
UCLA study shows tumors are not as addicted to glucose as previously thought
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered that squamous cell skin cancers do not require increased glucose to power their development and growth, contrary to a long-held belief about cancer metabolism.The findings could lead to a better understanding of the metabolic needs of many different types of cancer, and to the development of new cancer treatments. The research, led by senior authors Heather Christofk and Bill Lowry, was published in the journal Nature Communications.“These findings suggest that tumors are metabolically flexible an...
Source: UCLA Newsroom: Health Sciences - January 10, 2019 Category: Universities & Medical Training Source Type: news
